Jiangsu Nhwa Pharmaceutical (002262.SZ) obtains the Rightinoxacin Anfetamine Trinol Injection Drug Registration Certificate.

Enkang Pharmaceutical (002262.SZ) announced that the company recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug Ketoprofen Am inosulfonic acid Tramadol Injection. Ketoprofen Am inosulfonic acid Tramadol Injection is a non-steroidal anti-inflammatory analgesic, which is an inhibitor of both COX-1 and COX-2 activity. It is used as an adjunct to opioid analgesics for the treatment of acute moderate to severe postoperative pain in adults who are not suitable for oral administration.